NCT02920853

Brief Summary

The purpose of this study is to assess whether a novel, enhanced form of biofeedback can help individuals regulate their chronic musculoskeletal pain more effectively.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2016

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

September 26, 2016

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 30, 2016

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2018

Completed
Last Updated

August 21, 2018

Status Verified

August 1, 2018

Enrollment Period

1.9 years

First QC Date

September 26, 2016

Last Update Submit

August 17, 2018

Conditions

Keywords

chronic pain

Outcome Measures

Primary Outcomes (2)

  • Changes in clinical pain

    Self-report ratings of pain intensity, rated using 0-10 Likert-type scales, (i.e., 0 = no pain; 10 = most intense pain).

    Assessed daily via electronic diaries starting 1 week prior to session 1 and ending 1 week after session 10 (up to 11 weeks)

  • Changes in psychosocial outcomes

    Self-report ratings of pain interference, mood, sleep quality, and coping. These items are rated using 0-10 Likert-type scales, (e.g., 0 = no change; 10 = extreme change) with higher values indicating an increase in the variable assessed on a particular item (e.g., interference with daily activities).

    Assessed daily via electronic diaries starting 1 week prior to session 1 and ending 1 week after session 10 (up to 11 weeks)

Secondary Outcomes (1)

  • Changes in reactions to painful stimuli

    Assessed immediately before the first treatment session (Time 1) and immediately after (Time 2) the last treatment session (approximately 10 weeks from Time 1).

Study Arms (2)

BT-CPR

EXPERIMENTAL

Participants will receive training in relaxation and biofeedback to develop skills in relaxation/arousal reduction, and pain reduction. Then they will practice relaxing and reducing their arousal as they view graphical arousal feedback. Electric stimulations will be delivered throughout the biofeedback training to provide pain relief when relaxation is achieved.

Behavioral: Biofeedback Training (BT-CPR)

Biofeedback-Only

ACTIVE COMPARATOR

Participants will receive training in relaxation and biofeedback to develop skills in relaxation/arousal reduction, and pain reduction. Then they will practice relaxing and reducing their arousal as they view graphical arousal feedback.

Behavioral: Biofeedback Training

Interventions

Participants will receive biofeedback training (which will include electric stimulations) to reduce arousal and pain

BT-CPR

Participants will receive biofeedback training to reduce arousal and pain

Biofeedback-Only

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults (18 years or older) with a verified diagnosis of chronic musculoskeletal pain and currently experiencing pain

You may not qualify if:

  • under 18 years of age (given the nature of the treatment study)
  • if female, currently pregnant
  • persistent feelings of numbness in hands and feet
  • difficulty being able to feel or sense things
  • lack of access to a computer or smartphone (to complete electronic pain diaries)
  • injuries that prevent sensor application
  • use of narcotic pain medications with 48 hours of treatment sessions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Tulsa

Tulsa, Oklahoma, 74104, United States

Location

MeSH Terms

Conditions

Musculoskeletal PainChronic Pain

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jamie L Rhudy, PhD

    The University of Tulsa

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 26, 2016

First Posted

September 30, 2016

Study Start

September 1, 2016

Primary Completion

August 1, 2018

Study Completion

August 1, 2018

Last Updated

August 21, 2018

Record last verified: 2018-08

Data Sharing

IPD Sharing
Will not share

Locations